PirartJ.: Diabetes Mellitus and its degenerative complications: a prospective study of 4400 patients between 1947 and 1973.Diabetes Care1, 168–188, 1978.
2.
PickupJ.C., KeenH., ParsonJ.A., AlbertiK.G.M.M., RoweA.S.: Continuous subcutaneous insulin infusion: improved blood glucose and intermediary-metabolite control in diabetics.Lancet1, 1255–1257, 1979.
3.
PickupJ., TomeP.D., BilousR.W., KeenH., and AlbertiK.G.M.M..: Management of severely brittle diabetes by continuous subcutaneous and intramuscular insulin infusion: evidence for a deject in subcutaneous insulin absorption.Brit. Med. J.282, 347–350, 1981.
4.
BergerM., CüppersH.J., JörgensV., and BerchtoldP..: Absorption kinetics and biologic effects of subcutaneously injected insulin preparations.Diabetes Care5, 77–91, 1982.
BaylissG.: Brittle diabetes: long term control with a portable continuous, intravenous insulin infusion system.Brit. Med. J.283, 1207–1209, 1981.
8.
PickupJ.C., KeenH., ParsonJ.A., AlbertiK.G.M.M.: Continuous subcutaneous insulin infusion: an approach to achieving normal glycaemia.Brit. Med. J.1, 204–207, 1978.
9.
RizzaR.A., GerichJ.E., HaymondM.W., WestlandR.E., HallL.D., ClemensA.H., ServiceF.J.: Control of blood sugar in insulin-dependent diabetes: comparison of an artificial endocrine pancreas, continuous subcutaneous insulin infusion and intensified conventional insulin therapy.N. Engl. J. Med.303, 1313–1318, 1980.
10.
SaibeneV., MelandriM., BrembillaL., SpottiD., PozzaG.: Comparison between multi-injection and continuous subcutaneous insulin therapy in insulin-depedent diabetic inpatients.Acta Diabetol Lat.18, 45–50, 1981.
11.
BuysschaertM., MarchandE., KetelsegersJ.M., LambertA.E.: Comparison of plasma glucose and free insulin during CSII and intensified conventional insulin therapy.Diabetes Care6, 1–5, 1983.
12.
PoliM., SpottiD., BosiE., BrembillaL., PiattiP.M., MontiL., MiraltaF.: Single or multiple daily insulin injections and CSII in diabetes mellitus.Diabetologia21, 316, 1981 (Abstract).
13.
CalabreseG., BuetiA., SanteusanioF., GiomboliniA., ZegaG., AngelettiG., CartechiniM.G., BrunettiP.: Continuous subcutaneous insulin infusion in insulin-dependent diabetic patients: a comparison with conventional optimized treatment in a long term study.Diabetes Care5, 457–465, 1982.
14.
HomeP.D., CapaldoB., BurrinJ.M., WorthR., AlbertiK.G.M.M.: A crossover comparison of continuous subcutaneous insulin infusion (CSII) against multiple insulin injection in insulin-depedent diabetic subjects: improved control with CSII.Diabetes Care5, 466–471, 1982.
15.
SkylerJ.S., SeiglerD.E., ReevesM.L.: A comparison of insulin regimens in insulin-depedent diabetes mellitus.Diabetes Care5(suppl. 1), 11–18, 1982.
16.
ChampionM.C., ShepherdG., RodgerH.W., DuprèJ.: Continuous subcutaneous infusion of insulin in the management of diabetes mellitus.Diabetes29, 206, 1980.
17.
BarbosaJ., MenthL., EatonJ., SutherlandD., FreierE., and NajarianJ..: Long-term ambulatory, subcutaneous insulin infusion versus multiple daily injections in brittle diabetic patients.Diabetes Care4, 269–274, 1981.
18.
SchriffinA., BelmonteM.M.: Comparison between continuous insulin infusion and multiple injections of insulin. A one-year prospective study.Diabetes31, 255–264, 1981.
19.
TamborlaneW.V., SherwinR.S., RoivistoV., HendlerR., GeneralM., FeligP.: Normalization of the growth hormone and catekolamine response to exercise in juvenile-onset diabetics treated with a portable insulin infusion pump.Diabetes28, 785, 1979.
20.
PietriA., DunnF.L., and RaskinP..: The effect of improved diabetic control on plasma lipid and lipoprotein levels: a comparison of conventional therapy and continuous subcutaneous insulin infusion.Diabetes29, 1001–1005, 1980.
21.
ShadeD.S., EatonR.P., SpencerW.: Normalization of plasma insulin profiles in diabetic subjects with programmed insulin delivery.Diabetes Care3, 9–14, 1980.
22.
RaskinP., PietriA., UngerH.: Changes in glucagon levels after four to five weeks of glucoregulation by portable insulin infusion pumps.Diabetes28, 1033, 1979.
23.
TamborlaneW.V., HintzR.L., BergmanM., GeneralM., FeligP., SherwinR.S.: Insulin infusion pump treatement of diabetes: influence of improved metabolic control on plasma somatomedin levels.N. Engl. J. Med.305, 303–305, 1981.
24.
Policy Statement: Diabetes Care2: 140, 1980.
25.
Organizing Section: Diabetologia, March 1983.
26.
Lauritzen T., Frost-Larsen K., Larsen H.W., Deckert T. and the Steno Study Group: Effect of 1 year of near-normal blood glucose levels on retinopathy insulin dependent diabetics.Lancet1, 200–204, 1983.
27.
BuchwaldH., RoholT.D., DormanF.D., SkakoonJ.G., WignessB.D., ProsiF.R., TuckenE.M., RubleinT.G., BlackshearP.J., VarcoR.L.: A totally implantable drug infusion device: laboratory and clinical experience using a model with single flow rate and new design for modulated insulin infusion.Diabetes Care3, 351–358, 1980.
28.
SelamJ.L., SlingeneyerA., MedonB., MaresP., BernaurdJ.J., MirouzeJ.: Long-term ambulatory peritoneal insulin infusion of brittle diabetes with portable pumps: comparison with intravenous and subcutaneous routes.Diabetes Care6, 105–111, 1983.
